Research directly linked with GPELF activities (operational research): Essential tools - Diagnostics

American Journal of Tropical Medicine and Hygiene

Volumn 71, Issue 5 SUPPL., 2004, Pages 3-6

  Lammie, Patrick J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; BRUGIA; BRUGIA MALAYI; BRUGIA PAHANGI; BRUGIA TIMORI; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FILARIASIS; HUMAN; IMMUNOASSAY; LOA LOA; LYMPHATIC SYSTEM DISEASE; MANSONELLA; MEDICAL RESEARCH; NONHUMAN; PARASITE VECTOR; POLYMERASE CHAIN REACTION; REVIEW; SYSTEM ANALYSIS; WORLD HEALTH ORGANIZATION; WUCHERERIA BANCROFTI;

BRUGIA; BRUGIA MALAYI; BRUGIA PAHANGI; BRUGIA TIMORI; LOA LOA; MANSONELLA; WUCHERERIA; WUCHERERIA BANCROFTI;

EID: 10044281728     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2004.71.3     Document Type: Review

References (27)

1. WHO, 2000. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. Geneva: World Health Organization, www.filariasis.org.
2. More SJ, Copeman DB, 1990. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol 41: 403-406.
3. Weil GJ, Lammie PJ, Weiss N, 1997. The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 13: 401-404.
4. Sherchand JB, Obsomer V, Thankur JD, Hommel M, 2003. Mapping of lymphatic filariasis in Nepal. Filaria J 2: 7.
5. Weil GJ, Lammie PJ, Richards FO Jr, Eberhard ML, 1991. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin. J Infect Dis 164: 814-816.
6. Eberhard ML, Hightower AW, Addiss DG, Lammie PJ, 1997. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am J Trop Med Hyg 57: 483-486.
7. Chanteau S, Luquiaud P, Failloux AB, Williams SA, 1994. Detection of Wuchereria bancrofti larvae in pools of mosquitoes by the polymerase chain reaction. Trans R Soc Trop Med Hyg 88: 665-666.
8. Lizzotte MR, Supali T, Partono F, Williams SA, 1994. A polymerase chain reaction assay for the detection of Brugia malayi in blood. Am J Trop Med Hyg 51: 314-321.
9. Fischer P, Wibowo H, Pischke S, Ruckert P, Liebay E, Ismid IS, Supali T, 2002. PCR-based detection and identification of the filarial parasite Brugia timori from Alor Island, Indonesia. Ann Trop Med Parasitol 96: 809-821.
10. Toure FS, Mavoungo E, Kassambara L, Williams T, Wohl G, Millet P, Egwang TG, 1998. Human occult filariasis: field evaluation of a nested polymerase chain reaction assay for the detection of occult infection. Trop Med Int Health 3: 505-511.
11. Fischer P, Buttner DW, Bamuhiiga J, Williams SA, 1998. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am J Trop Med Hyg 58: 816-820.
12. Williams SA, Laney SJ, Biewert L, Saunders LJ, Boakye DA, Fischer P, Goodman DS, Helmy H, Hoti SL, Lammie PJ, Plichart C, Ramzy R, Ottesen EA, 2002. The mosquito PCR project: to develop a rapid assessment tool for the detection of Wuchereria bancrofti infected mosquitoes. Ann Trop Med Parasitol 96 (Suppl): 541-546.
13. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 347: 1841-1848.
14. Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG, 2003. PCR and mosquito dissection as tools to monitor filarial infection levels following mass treatment. Filaria J 2: 11.
15. Ramzy RMR, Helmy H, Faris R, Gad AM, Chandrasheka R, Weil GJ, 1995. Evaluation of a recombinant antigen-based antibody assay for diagnosis of bancroftian filariasis in Egypt. Ann Trop Med Parasitol 89: 443-446.
16. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Farris R, 1999. A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow up. Am J Trop Med Hyg 61: 53-58.
17. Rahmah N, Lim BH, Anuar AK, Shenoy RK, Kumaraswami V, Hakim SL, Chotechuang P, Kanjanopas K, Ramachandran CP, 2001. A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi infection. Trans R Soc Trop Med Hyg 95: 280-284.
18. Rahmah N, Taniawati S, Shenoy RK, Lim BH, Kumaraswami V, Anuar AK, Hakim SL, Hayati MIN, Chan BT, Suharni M, Ramachandran CP, 2001. Specificity and sensitivity of a rapid dipstick test (Brugia Rapid) in the detection of Brugia malayi infection. Trans R Soc Trop Med Hyg 95: 601-604.
19. Rahmah N, Shenoy RK, Nutman TB, Weiss N, Gilmour K, Maizels RM, Yazdanbakhsh M, Sartono E, 2003. Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Trop Med Int Health 8: 895-900.
20. Rodriguez-Perez MA, Danis-Lozano R, Rodriguez MH, Bradley JE, 1999. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. Trop Med Int Health 4: 98-104.
21. Gao CL, Cao WC, Chen CC, 1994. Changes in anti-filarial antibody after control of filariasis in Shandong Province. Chin Med J 107: 360-363.
22. Lammie PJ, Weil GJ, Rahmah N, Kaliraj P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen E, 2004. Recombinant antigen-based assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J 3: 9.
23. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux J-P, 1997. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 18-22.
24. Noma M, Nwoke BEB, Nutall I, Tambala PA, Enyong P, Namsenmo A, Remme J, Amazigo UV, Kale OO, Sékétéli A, 2002. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96 (Suppl 1): 29-40.
25. Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH, 2000. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356: 1077-1078.
26. Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB, Eka BL, Enyong P, Meli J, Kale O, Remme JH, 2002. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 80: 852-858.
27. Klion AD, Vijaykumar A, Oei T, Marlin B, Nutman TB, 2003. Serum immunoglobulin G4 antibodies to the recombinant antigen L1-SXP-1 are highly specific for Loa loa infection. J Infect Dis 187: 128-133.